LifeVantage Corporation

LifeVantage Corporation

LFVNNYSE / NASDAQConsumer DefensiveSmall cap

$4.15-$0.74 (-15.1%)

Last close · Data as of Nov 20, 2026

Market cap
$117.5M
P/E
12.0x
EV / EBITDA
7.1x
Revenue
$228.5M
Net margin
4.3%
ROCE
27.3%

-34.2% over the last year

LifeVantage Corporation price, 1Y

Daily closes.

Go deeper

Technical chart: candles, 28 indicators including moving averages, RSI and MACD, drawing tools and five colour themes

Open technical chart
Open technical chartCandles, 28 indicators, drawing tools

Performance

Price return, before dividends, to the 20 Nov 2026 close.

1M
-30.5%
3M
-37.6%
6M
-21.0%
1Y
-34.2%
5Y
-43.8%

52-week range

Day change -$0.74 (-15.1%) from $4.89 to $4.15 · Last close Nov 20, 2026

Best weekday to invest, historically

The same weekly amount in LFVN, bought on each weekday since 2021.

News & filings

What LifeVantage filed, who traded, and what's next

How to read this

"News & filings" lists what the company itself has put on record with regulators, who inside it traded, the news that names it, and the next date we know of. Filings and releases are first-hand; news is third-party and may be thin for smaller companies. A day of insider filings is one row. Nothing here is a recommendation.

AI Summary

US Stock

StrengthOperating profit was more than a hundred times interest costs.

Concerns (1)

  • The price is 28.9% below its 200-day average, and the 50-day average is below the 200-day.

Prices to the 20 Nov 2026 close · Financial year: fiscal 2025

Rule-based from financial data. Not advice.

About the company

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, weight management, pre and pro-biotics and skin and hair care products internationally.

Read moreShow less

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, weight management, pre and pro-biotics and skin and hair care products internationally. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 and Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; LifeVantage Daily Wellness, a dietary supplement to strengthen immune health; LifeVantage Rise AM and Reset PM System that provides the body with the right nutrients; LifeVantage D3+, a dietary supplement that provides vitamin D3 and K2, magnesium, calcium, and other trace minerals to support a balanced immune system, strong bones, and cardiovascular health; PhysIQ Fat Burn to support weight management; PhysIQ Prebiotic is a dietary supplement designed to support the good bacteria in the gut and a healthy microbiome; MindBody GLP-1 System, a dietary supplement that combines two products, MB Core and MB Enhance, which are designed to support weight management and wellness by activating GLP-1 naturally and balancing signals along the gut-brain axis; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix. It also provides anti-aging skin care products, such as liquid collagen, facial cleansers, eye cream, moisturizing cream, sunscreen, perfecting lotions, and hand creams, as well as shampoos, nourishing conditioners, and scalp serums under the TrueScience brand name. It sells its products through its website and network of independent consultants. LifeVantage Corporation is based in Lehi, Utah.

Sector
Consumer Defensive
Shares outstanding
12.4M

Valuation, profitability, growth and solvency at the latest close; hover a label for its meaning.

Valuation

Market cap
$117.5M
P/E
12.0x
P/B
3.4x
EV / EBITDA
7.1x
EV / Sales
0.5x
P/S
0.5x
52-week high
$10.70
52-week low
$4.02

Profitability

Operating margin
5.3%
Net margin
4.3%
EBITDA margin
6.7%
ROE
28.3%
ROCE
27.3%
ROIC
37.4%
ROA
13.6%
Asset turnover
3.18

Growth

Revenue
$228.5M
Revenue growth, 1Y
14.2%
Revenue CAGR, 3Y
3.5%
Net profit growth, 1Y
233.8%

Solvency

Current ratio
1.87
Debt / Equity
0.34
Debt / Assets
0.16
CFO / Net profit
1.21
Cash / Market cap
17.2%

Where the revenue went

Of every $100 of FY2025 revenue, $4 was left as net income.

LifeVantage Corporation income statement flow, FY2025
LifeVantage Corporation income statement flow, FY2025: flows
FromToAmount
RevenueCost of revenue$44.9M
RevenueGross profit$183.7M
Gross profitSelling, general and administrative$69.2M
Gross profitOther operating expenses$102.3M
Gross profitOperating income$12.2M
Operating incomePretax income$12.2M
Interest and other incomePretax income$40.0k
Pretax incomeTax and other$2.4M
Pretax incomeNet income$9.8M

Revenue and net profit

Revenue grew 14.2% in FY2025; net profit is the dashed line.

LifeVantage Corporation revenue and net profit by fiscal year
LifeVantage Corporation revenue and net profit by fiscal year
DateRevenueNet profit
FY2022$206.4M$3.1M
FY2023$213.4M$2.5M
FY2024$200.2M$2.9M
FY2025$228.5M$9.8M

Cash flows

Cash from operations, with free cash flow as the dashed line.

LifeVantage Corporation operating and free cash flow by fiscal year
LifeVantage Corporation operating and free cash flow by fiscal year
DateOperating cash flow
FY2022$8.0M
FY2023$6.8M
FY2024$12.2M
FY2025$11.9M

Growth

Latest fiscal year 2025: each figure with its change over the year before.

Revenue
$228.5M+14.2%1Y
EBITDA
$15.4M+94.0%1Y
Net profit
$9.8M+233.8%1Y
Cash from operations
$11.9M-2.6%1Y
Revenue CAGR, 3Y
3.5%
Net profit CAGR, 3Y
46.5%
YearRevenueEBITDANet profitFCFROERevenue growth 1YNet profit growth 1Y
FY2025$228.5M$15.4M$9.8M—28.3%+14.2%+233.8%

Monthly returns

Month-by-month returns of LFVN across the years, with the seasonal pattern.

Balance sheet

What the company owns and owes at the end of FY2025.

LineFY2025
Assets$72.0M
Liabilities$37.3M
Equity$34.6M
Paid-in capital$140.0M

Market cap against peers

8 peers: same sector, nearest by size.

Peers map

Consumer Defensive companies placed by value, growth and quality; LFVN highlighted.

P/E against peers

LFVN trades at 12.0x earnings against a peer median of -1.3x.

  1. LifeVantage Corporation (this company)12.0x

Peer comparison

Same-sector peers by market cap, with the median.

CompanyMarket capP/EP/BROEEV/EBITDA
LifeVantage CorporationLFVNthis company$117.5M12.0x3.4x28.3%7.1x
BRC Inc.BRCC$149.8M-12.6x3.3x-26.1%-16.7x
Zevia PBCZVIA$100.5M-10.1x2.0x-19.4%-8.7x
HF Foods Group Inc.HFFG$98.4M-2.5x0.5x-19.2%-57.5x
Ispire Technology Inc.ISPR$95.3M—158.8x-6540.0%—
Solesence, Inc.SLSN$95.0M53.1x5.4x10.2%32.0x
FitLife Brands, Inc.FTLF$93.3M14.8x2.1x14.5%13.0x
SkinHealth Systems Inc.SKIN$79.1M—1.3x-15.6%5.8x
The Hain Celestial Group, Inc.HAIN$69.0M-0.1x0.1x-111.8%-1.9x
Peer median—-1.3x2.1x-19.3%-1.9x

Year-to-date ROI

LFVN since 1 January, against earlier years.

Historical volatility

LFVN's day-to-day swings over 30, 60 and 180 days.

Financial statements

Income statement, balance sheet and cash flow as reported, grouped into plain-language lines.

Consolidated figures in USD, fiscal years, newest first.

Operating margin by fiscal year

LifeVantage Corporation operating margin by fiscal year
LifeVantage Corporation operating margin by fiscal year
DateOperating margin
FY20223.7%
FY20232.0%
FY20242.2%
FY20255.3%
LineFY2025
Cost of revenueCost Of Revenue$44.9M
Gross profitGross Profit$183.7M
Operating expensesOperating Expense$171.5M
Other operating expensesOther Operating Expenses$102.3M
Total expensesTotal Expenses$216.3M
Pretax incomePretax Income$12.2M

Learn while you research

Academy chapters picked for LifeVantage Corporation and the metrics on this page.

  1. 01 Stock Valuation BasicsHow to think about what a fair price for a stock looks like.7 min read
  2. 02 Value InvestingA P/E of 12.0 could be a value opportunity, or a value trap. Know the difference.7 min read
  3. 03 Stock Market RisksSmall caps carry concentrated, idiosyncratic risk, learn to manage it.6 min read
  4. 04 Cyclical vs Defensive StocksConsumer staples behave defensively across the business cycle.6 min read
  5. 05 Essential Stock RatiosP/E, P/B, EV/EBITDA, what they mean and when to use each.7 min read
  6. 06 How to Read a Cash-Flow StatementProfit can be manipulated; cash flow rarely lies.7 min read
Browse the full Equiscale Academy →